Plexus Corp. reports fiscal Q3 results on July 30 with the stock down 13% over the past month and options traders meaningfully more cautious than their recent baseline — yet short sellers are not pressing the bear case harder.
The clearest shift this week is in options positioning. The put/call ratio has climbed to 0.26, running well above its 20-day average of 0.17 and about 1.5 standard deviations above the norm — the most defensive reading since late June. That marks a decisive break from the flat, call-heavy profile the options market held through most of July. The move coincides with the stock's pullback to $250, down from above $290 in mid-June, and suggests hedging demand has picked up as investors approach the print.
Short interest tells a calmer story. Bears hold about 3.1% of the free float — a modest level — and the position has drifted only fractionally higher on the week, up roughly 1%. Borrow conditions offer no signal of escalating conviction: cost to borrow is running below 0.42%, down 6% on the week and near its lowest level of the past several months. Availability is extraordinarily loose at over 6,600% — roughly 10 million shares available to lend versus the roughly 832,000 currently borrowed — meaning any short seller wanting exposure faces no friction whatsoever. The lending market is not the story here.
What is worth watching is the Street's framing versus where the stock now trades. Analysts who have covered PLXS remain broadly bullish, with Stifel raising its target to $330 in late June and Needham lifting to $310 earlier that month — both maintaining Buy ratings. The consensus mean target of $293 now sits above the current price of $250, implying roughly 17% return potential on the Street's numbers. Bulls point to deepening exposure in aerospace, defense, and semiconductor capital equipment as structural demand drivers. Bears flag a stalled commercial aerospace recovery and potential normalization of SemiCap spend as the risks most likely to disappoint. Valuation has compressed alongside the price decline: the P/E has shed more than 4.5 points over the past 30 days to around 28x, and EV/EBITDA has eased to roughly 17x. The ORTEX short score is a quiet 34, and factor rankings are middling across the board — no extreme readings in either direction.
CEO Todd Kelsey has been a consistent seller. He sold shares in three separate clusters — early June, mid-June, and again on July 15 — collecting roughly $1.1 million across those transactions in total. The sales are small as a percentage of the company and carry low significance scores, consistent with a planned-distribution pattern rather than an urgent exit. Still, the cadence is notable: Kelsey has been trimming into every price rally over the past two months, including at levels above $290 in June. The 90-day net insider figure is technically positive at around 26,000 shares, but this appears to reflect stock-award vesting rather than open-market buying.
Within the EMS peer group, PLXS's week looks comparatively orderly. BHE fell 9% on the week, BELF.A dropped 11%, and TTMI was down a steep 26% — making PLXS's 4% decline look contained by comparison. The prior April earnings print produced a 5.6% one-day gain and a 4% five-day follow-through, the most relevant recent reaction data available. The July 30 print will therefore be less about whether Plexus is growing and more about whether its guidance into aerospace and SemiCap end markets justifies the re-rating the stock has received year-to-date — and whether the CEO's continued selling reflects discipline or something more cautious about the near-term setup.
See the live data behind this article on ORTEX.
Open PLXS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
